You can’t flush plaque out of your arteries with a supplement or a juice cleanse, but you can shrink it. Research using imaging inside coronary arteries shows that plaque volume measurably decreases when LDL cholesterol drops below about 75 mg/dL and stays there. That process takes roughly two years of sustained effort, combining dietary changes, exercise, and often medication. The goal isn’t a spotless artery; it’s smaller, more stable plaque that’s far less likely to rupture and cause a heart attack.
What “Cleaning” Your Arteries Actually Means
Arterial plaque isn’t like gunk in a pipe. It’s a living, inflamed mass of cholesterol, immune cells, and scar tissue embedded in the artery wall. When cholesterol levels stay high, immune cells called macrophages gorge on it, swell into “foam cells,” and die, leaving behind a soft, unstable core. A thin cap over that core can crack open, triggering a blood clot that blocks the artery entirely.
Plaque regression, the clinical term for shrinking plaque, works through two main pathways. First, lowering cholesterol in the blood reduces the raw material that feeds plaque growth. Second, the body’s own cleanup crew (those same macrophages) can begin clearing dead cells and pulling cholesterol back out of the artery wall through a process called reverse cholesterol transport, carried largely by HDL particles. Reducing inflammation in the artery wall makes this cleanup more effective and thickens the fibrous cap over existing plaque, making it far less likely to rupture.
The LDL Target That Stops Plaque Growth
A long-term study published in Circulation tracked patients with ultrasound imaging inside their coronary arteries for at least 12 months. It found a clear, linear relationship between LDL cholesterol and plaque growth. The critical threshold: an LDL of about 75 mg/dL. Below that level, plaque stopped growing on average. Above it, plaque expanded in proportion to how high LDL climbed. Among patients on cholesterol-lowering medication specifically, the cutoff was nearly identical at 72.5 mg/dL.
The study also identified a useful ratio. When LDL divided by HDL fell below 1.3, plaque growth halted. So it’s not just about pushing LDL down; raising HDL contributes too. For context, the average American adult has an LDL around 110 to 120 mg/dL, well above the regression threshold.
How Long Regression Takes
A systematic review of plaque regression studies found that measurable shrinkage occurred after an average of 19.7 months of treatment. That’s roughly two years of consistently low cholesterol levels before imaging can detect a meaningful reduction in plaque size. The review’s authors suggested patients should maintain aggressive cholesterol lowering for approximately two years before reassessing their approach. This isn’t a quick fix. It’s a slow biological remodeling of tissue inside artery walls.
Diet Changes That Move the Needle
The PREDIMED trial, one of the largest diet studies ever conducted, assigned thousands of people at high cardiovascular risk to either a Mediterranean diet supplemented with extra-virgin olive oil, a Mediterranean diet supplemented with mixed nuts, or a standard low-fat control diet. After about 4.8 years, the Mediterranean diet groups had 30% fewer heart attacks, strokes, and cardiovascular deaths.
In a subset of participants who underwent carotid artery ultrasound at around 2.4 years, the results were striking. Artery wall thickness (a marker of plaque buildup) progressed in the control group but actually regressed in the group eating a Mediterranean diet with nuts. Plaque height grew in the control group while it stayed flat or slightly shrank in the nut-supplemented group. Interestingly, the olive oil group didn’t show the same measurable regression on imaging, though it still had better cardiovascular outcomes overall.
The practical takeaway: a diet built around vegetables, fruits, legumes, whole grains, fish, olive oil, and nuts can slow or reverse the physical thickening of artery walls over a couple of years. This isn’t about one magical food. It’s the overall dietary pattern that shifts cholesterol levels, reduces inflammation, and gives the body’s repair systems a chance to work.
Why Quitting Smoking Matters for Plaque Stability
Smoking doesn’t just accelerate plaque growth. It actively undermines plaque stability, making existing deposits more dangerous. A study using high-resolution imaging inside coronary arteries found that people who continued smoking while on cholesterol-lowering medication had far less plaque stabilization than those who quit. At the one-year mark, people who stopped smoking saw their rate of thin-capped, rupture-prone plaques drop from 62.5% to 12.5%, nearly identical to the improvement seen in people who had never smoked. Continued smokers didn’t get that benefit even with medication.
Quitting smoking also restores the function of the artery lining within about a year. That lining, when healthy, resists cholesterol penetration and inflammation. Damaging it is one of the earliest steps in plaque formation.
When Medication Becomes Necessary
For many people, diet and exercise alone won’t push LDL below 75 mg/dL. That’s where cholesterol-lowering medications come in. Statins remain the first-line treatment and are the drugs most consistently shown to produce plaque regression in imaging studies. They work by reducing the liver’s cholesterol production and lowering inflammation in artery walls simultaneously.
For people who can’t reach target levels on statins alone, a newer class of injectable medications (PCSK9 inhibitors) can drive LDL dramatically lower. A meta-analysis of randomized trials presented through the American Heart Association found that these drugs reduced the percentage of artery volume occupied by plaque by about 1% and total plaque volume by over 6 cubic millimeters compared to standard care. That may sound small, but in a coronary artery just 3 to 4 millimeters wide, it represents a meaningful reduction in blockage and, more importantly, in the risk of a rupture event.
How Plaque Changes Are Tracked
Two main imaging tools let doctors monitor what’s happening inside your arteries. A coronary artery calcium (CAC) score uses a quick, non-contrast CT scan to measure calcified plaque. It’s widely available, inexpensive, and strongly predicts heart attack and overall mortality risk. However, it only captures hard, calcified deposits and can paradoxically rise even as plaque stabilizes, because soft dangerous plaque sometimes calcifies as it heals.
Coronary CT angiography (CCTA) provides a more detailed picture. It visualizes both calcified and non-calcified plaque, shows the degree of artery narrowing, and can identify the soft, fatty deposits most prone to rupture. This type of imaging is increasingly used to evaluate how individuals respond to treatment over time. Neither test is typically ordered for routine screening in low-risk people, but for someone with known plaque or elevated risk, serial imaging can confirm whether a treatment plan is working.
What You Can Do Starting Now
The evidence points to a consistent set of strategies that, together, give your body the best chance of stabilizing and shrinking arterial plaque:
- Shift toward a Mediterranean-style diet. Emphasize nuts, olive oil, fish, legumes, vegetables, and whole grains. Reduce processed meats, refined carbohydrates, and foods high in saturated fat.
- Get LDL cholesterol tested and track it. The regression threshold is around 75 mg/dL. If your level is well above that, lifestyle changes alone may not be enough, and medication is worth discussing.
- Stop smoking. Plaque stabilization benefits appear within a year of quitting and match those of people who never smoked.
- Exercise regularly. Aerobic activity raises HDL, lowers blood pressure, and reduces the chronic inflammation that drives plaque growth. Even moderate activity like brisk walking makes a measurable difference.
- Be patient. Measurable plaque regression takes close to two years on average. Consistency matters far more than intensity in any single week.
No supplement, detox, or chelation therapy has been shown in rigorous trials to shrink coronary plaque. The approaches that work are unglamorous but well-proven: lower your cholesterol enough, keep inflammation down, and give your body time to do its own repair work.